Perturbation of the Preterm Human Immune System in Early Life

Benjamin A Fensterheim1,2, Michelle McKeague3,2, Divij Mathew3,2

  • 1Department of Pediatrics, Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Insights

Severe bronchopulmonary dysplasia (BPD) in preterm infants increases Th17 cells and neutrophils. Systemic infections trigger distinct, persistent T cell responses, showing comorbidities uniquely impact neonatal immunity.

Area of Science:

  • Neonatal immunology
  • Immunocompromised infants
  • Preterm birth complications

Background:

  • Inflammatory complications are frequent in preterm infants.
  • Their impact on neonatal immune development is not well understood.
  • Bronchopulmonary dysplasia (BPD) and systemic infections are major preterm complications.

Purpose of the Study:

  • To investigate distinct immune signatures of BPD and systemic infection in preterm infants.
  • To track changes in immune composition over time.
  • To understand how these conditions affect neonatal immune development.

Main Methods:

  • Longitudinal high-dimensional immune profiling.
  • Analysis of residual whole blood from preterm and term infants.
  • Bi-weekly sampling of preterm infants over time.

Main Results:

  • Severe BPD associated with increased Th17 CD4+ T cells, neutrophils, and Th17 cytokines.
  • Systemic infections induced robust CD8+, CD4+, and γδ T cell responses.
  • Infection-induced immune responses showed oligoclonal expansion and persistent changes.

Conclusions:

  • Different preterm comorbidities imprint the neonatal immune system distinctively.
  • Longitudinal immune profiling reveals divergent immune trajectories.
  • Findings may identify targets for therapeutic interventions in preterm infants.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
793
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.5K